Non-high-density lipoprotein cholesterol (non-HDL-C) also contributes to the impairment of NO bioavailability by increasing the production of reactive oxygen species and inhibiting eNOS activity, leading to endothelial dysfunction and atherosclerosis [83]. This evidence concerns the gene NOS3 and atherosclerosis.